Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients : a systematic review and meta-analysis

Fawaz, Sarah, Barton, Stephen and Nabhani-Gebara, Shereen (2020) Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients : a systematic review and meta-analysis. Research Square, (Unpublished)

Full text available as:
[img]
Preview
Text
Fawaz-S-45420-VoR.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Abstract Background: Recently, continuous administration of piperacillin-tazobactam has been proposed as a valuable alternative to traditional intermittent administration especially in critically ill patients. However, antibiotic dosing remains a challenge for clinicians as antibiotic dosing regimens are usually determined in non-critically-ill hospitalized adult patients. The aim was to conduct a systematic review to identify and highlight studies comparing clinical outcomes of piperacillin tazobactam dosing regimens, continuous/prolonged infusion vs intermittent infusion in critically ill patients. Meta-analyses were performed to assess the overall effect of dosing regimen on clinical efficacy. Methods: Studies were identified systematically through searches of PubMed and Science Direct, in compliance with PRISMA guidelines. Following the systematic literature review, meta-analyses were performed using Review Manager. Results: Twenty-three studies were included in the analysis involving 3828 critically ill adult participants in total (continuous/prolonged infusion = 2197 and intermittent infusion = 1631) from geographically diverse regions. Continuous/prolonged resulted in significantly: higher clinical cure rates (OR 1.56, 95% C.I 1.28-1.90, P = 0 .0001), lower mortality rates (OR 0.68, 95% C.I 0.55-0.84, P = 0 .0003), higher microbiological success rates (OR 1.52, 95% C.I 1.10-2.11, P = 0.01) and decreasing the length of hospital stay (OR -1.27, 95% C.I -2.45—0.08, P = 0.04) in critically ill patients. Conclusion: There is a significant level of evidence that clinical outcome in critically ill patients is improved in patients receiving piperacillin-tazobactam via continuous/prolonged infusion. Therefore, this alternative infusion strategy could be recommended in clinical practice.

Item Type: Article
Research Area: Pharmacy
Faculty, School or Research Centre: Faculty of Science, Engineering and Computing
Faculty of Science, Engineering and Computing > School of Life Sciences, Pharmacy and Chemistry
Related URLs:
SWORD Depositor: Mr Jisc Router
Depositing User: Mr Jisc Router
Date Deposited: 13 May 2020 08:48
Last Modified: 13 May 2020 08:48
DOI: https://doi.org/10.21203/rs.2.24493/v1
URI: http://eprints.kingston.ac.uk/id/eprint/45420

Actions (Repository Editors)

Item Control Page Item Control Page